News

6 October 2024

Liverpool to lead national healthcare research Hub for Advanced Long-acting Therapeutics

12 March 2024

University plays key role in Investment Zone plans

7 August 2023

Liverpool host LONGEVITY consortium

6 July 2023

£1.68m awarded to University researcher for drug safety in pregnancy

26 June 2023

Researchers continue to support global understanding of COVID-19

18 February 2023

LAPaL, the Long-Acting Therapeutics Patents and Licences Database, is now available with enhanced features to track new drug development

13 January 2023

Developing the Long-acting Pipeline: Data analysis, Modelling and accelerating development of Long-acting therapeutics

21 December 2022

Elliot Croft Wins the Roy Mapstone Prize for Developing Novel Long-Acting Microarray Patches at the 27th Ophthalmology and Vision Science Research Prize Meeting

5 December 2022

Off-patent liver disease drug could prevent COVID-19 infection

2 December 2022

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

12 September 2022

Taking control of the HIV epidemic – How long-acting injectables can help reach ambitious targets

29 July 2022

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

29 July 2022

Community engagement – shaping the long-acting technologies pipeline

26 July 2022

Becoming an Expert: Studying how long-acting drug delivery formulations interact with the human immune system

25 April 2022

Delivering innovations to low- and middle-income countries

24 April 2022

Saving lives through long-acting injectable innovation

24 March 2022

Exchanging knowledge at the edge of pharmacology and materials chemistry

24 March 2022

Living with TB - my experience

24 March 2022

Reducing the burden of TB in the world’s most in need communities with long-acting injectables

24 March 2022

Investing in TB prevention strategies with Long-Acting injectables